Induction of erythroid differentiation and increased globin mRNA production with furocoumarins and their photoproducts

Journal of Photochemistry and Photobiology B: Biology

Volumn 121, Issue , 2013, Pages 57-66

  Salvador, Alessia ^a   Brognara, Eleonora ^b   Vedaldi, Daniela ^a   Castagliuolo, Ignazio ^a   Brun, Paola ^a   Zuccato, Cristina ^b   Lampronti, Ilaria ^b   Gambari, Roberto ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

Author keywords

Angelicin; Erythroid differentiation; Fetal hemoglobin; K562 cells; Photoproducts; Psoralen

Indexed keywords

FUROCOUMARIN; GLOBIN MESSENGER RNA;

ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CYTOFLUOROMETRY; DNA BINDING; ERYTHROID CELL; HUMAN; HUMAN CELL; IRRADIATION; PHOTOLYSIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ULTRAVIOLET A RADIATION;

CELL CYCLE; CELL DIFFERENTIATION; CELL SURVIVAL; ERYTHROID CELLS; GENE EXPRESSION REGULATION; GLOBINS; HUMANS; K562 CELLS; LIGHT; MOLECULAR STRUCTURE; PHOTOSENSITIZING AGENTS; PSORALENS; RNA, MESSENGER;

EID: 84875036770     PISSN: 10111344     EISSN: 18732682     Source Type: Journal    
DOI: 10.1016/j.jphotobiol.2013.02.011     Document Type: Article

References (36)

1. F. Dall'Acqua, G. Viola, and D. Vedaldi W.F. Hoorspool, F. Lenci, Molecular basis of psoralen photochemotherapy CRC Handbook of Organic Photochemistry and Photobiology 2004 CRC Press Boca Raton pp. 142/1-17
2. R. Edelson, C. Berger, F. Gasparro, B. Jegasothy, P. Heald, B. Wintroub, E. Vonderheid, R. Knobler, K. Wolff, G. Plewig, G. McKiernan, I. Christiansen, M. Oster, H. Höningsmann, H. Wilford, E. Kokoschka, T. Rehle, M. Perez, G. Stingl, and L. Laroche Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy New Engl. J. Med. 316 1987 297 303
3. J.A. Parrish, T.B. Fitzpatrick, L. Tanenbaum, and M.A. Pathak Photochemotherapy of psoriasis with oral methoxsalen and long-wave ultraviolet light New Engl. J. Med. 291 1974 1207 1212
4. J.J. Luszczki, M. Andres-March, M. Gleńsk, and K.S. Skalicka-Woźniak Anticonvulsant effects of four linear furanocoumarins, bergapten, imperatorin, oxypeucedanin, and xanthotoxin, in the mouse maximal electroshock-induces seizure model: a comparative study Pharmacol. Rep. 62 2010 1231 1236
5. A. Tamanini, M. Borgatti, A. Finotti, L. Piccagli, V. Bezzerri, M. Favia, L. Guerra, I. Lampronti, N. Bianchi, F. Dall'Acqua, D. Vedaldi, A. Salvador, E. Fabbri, I. Mancini, E. Nicolis, V. Casavola, G. Cabrini, and R. Gambari Trimethylangelicin reduces IL-8 transcription and potentiates CFTR function Am. J. Physiol. Lung Cell. Mol. Physiol. 300 2011 L380 L390
6. D.Z. Tang, F. Yang, Z. Yang, J. Huang, Q. Shi, D. Chen, and Y.L. Wang Psoralen stimulates osteoblast differentiation through activation of BMP signalling Biochem. Biophys. Res. Commun. 405 2011 256 261
7. G. Viola, D. Vedaldi, F. Dall'Acqua, E. Fortunato, G. Basso, N. Bianchi, C. Zuccato, M. Borgatti, I. Lampronti, and R. Gambari Induction of γ-globin mRNA, erythroid differentiation and apoptosis in UVA-irradiated human erythroid cells in the presence of furocoumarin derivatives Biochem. Pharmacol. 75 2008 810 825
8. G. Viola, A. Salvador, D. Vedaldi, F. Dall'Acqua, N. Bianchi, C. Zuccato, M. Borgatti, I. Lampronti, and R. Gambari Differentiation and apoptosis in UVA-irradiated cells treated with furocoumarin derivatives Ann. NY Acad. Sci. 1171 2009 334 344
9. I. Lampronti, N. Bianchi, M. Borgatti, E. Fibach, E. Prus, and R. Gambari Accumulation of γ-globin mRNA in human erythroid cells treated with angelicin Eur. J. Haematol. 71 2003 189 195
10. R. Gambari, and E. Fibach Medicinal chemistry of fetal hemoglobin inducers for treatment of β-thalassemia Curr. Med. Chem. 14 2007 199 212
11. C.B. Lozzio, and B.B. Lozzio Human chronic leukemia cell-line with positive philadelphia chromosome Blood 45 1975 321 333
12. N. Bianchi, C. Zuccato, A. Finotti, I. Lampronti, M. Borgatti, and R. Gambari Involvement of miRNA in erythroid differentiation Epigenomics 4 2012 51 65
13. R. Gambari Alternative options for DNA-based experimental therapy of β-thalassemia Expert Opin. Biol. Ther. 12 2012 443 462
14. S. Caffieri, F. Di Lisa, F. Bolesani, M. Facco, G. Semenzato, F. Dall'Acqua, and M. Canton The mitochondrial effects of novel apoptogenic molecules generated by psoralen photolysis as a crucial mechanism in PUVA therapy Blood 109 2007 4988 4994
15. A.Y. Potapenko, A.A. Kyagova, L.N. Bezdetnaya, E.P. Lysenko, I.Y. Chernyakhovskaya, V.A. Bekhalo, E.V. Nagurskaya, V.A. Nesterenko, N.G. Korotky, S.N. Akhtyamov, and T.M. Lanshchikova Products of psoralen photooxidation possess immunomodulative and antileukemic effects Photochem. Photobiol. 60 1994 171 174
16. A. Salvador, S. Dall'Acqua, M. Sutera Sardo, S. Caffieri, D. Vedaldi, F. Dall'Acqua, M. Borgatti, C. Zuccato, N. Bianchi, and R. Gambari Erythroid induction of chronic myelogenous leukemia K562 cells following treatment with photoproduct derived from the UV-A irradiation of 5-methoxypsoralen ChemMedChem 5 2010 1506 1512
17. S. Chimichi, M. Boccalini, B. Cosimelli, G. Viola, D. Vedaldi, and F. Dall'Acqua A convenient synthesis of psoralens Tetrahedron 58 2002 4859 4863
18. F. Bordin, F. Dall'Acqua, and A. Guiotto Angelicins, angular analogs of psoralens: chemistry, photochemical, photobiological and phototherapeutic properties Pharmacol. Ther. 52 1991 331 363
19. G. Viola, M. Boccalini, E. Fortunato, F. Dall'Acqua, and S. Chimichi Synthesis and photobiological properties of bromo- and alkoxymethylfurocoumarins Lett. Drug Des. Discov. 5 2008 93 103
20. P. Barraja, L. Caracausi, P. Diana, A. Carbone, A. Montalbano, G. Cirrincione, P. Brun, G. Palù, I. Castagliuolo, F. Dall'Acqua, D. Vedaldi, and A. Salvador Synthesis of pyrrolo[3,2-h]quinolinones with good photochemotherapeutic activity and no DNA damage Bioorg. Med. Chem. 18 2010 4830 4843
21. A. Szulawska, J. Arkusinska, and M. Czyz Accumulation of γ-globin mRNA and induction of irreversible erythroid differentiation after treatment of CML cell line K562 with new doxorubicin derivatives Biochem. Pharmacol. 73 2007 175 184
22. S. Salvioli, A. Ardizzoni, C. Franceschi, and A. Cossarizza JC-1, but not DiOC6(3) or rhodamine 123, is a reliable fluorescent probe to assess delta psi changes in intact cells: implications for studies on mitochondrial functionality during apoptosis FEBS Lett. 411 1997 77 82
23. P. Kaewsuya, N.D. Danielson, and D. Ekhterae Fluorescent determination of cardiolipin using 10-N-nonyl acridine orange Anal. Bioanal. Chem. 387 2007 2775 2782
24. C. Chiarabelli, N. Bianchi, M. Borgatti, E. Prus, E. Fibach, and R. Gambari Induction of gamma-globin gene expression by tallimustine analogs in human erythroid cells Haematologica 88 2003 826 827
25. N. Bianchi, F. Osti, C. Rutigliano, F.G. Corradini, E. Borsetti, M. Tomassetti, C. Mischiati, G. Feriotto, and R. Gambari The DNA-binding drugs mithramycin and chromomycin are powerful inducers of erythroid differentiation of human K562 cells Brit. J. Haematol. 104 1999 258 265
26. I. Lampronti, N. Bianchi, C. Zuccato, F. Dall'Acqua, D. Vedaldi, G. Viola, R. Potenza, F. Chiavilli, G. Breveglieri, M. Borgatti, A. Finotti, G. Feriotto, F. Salvatori, and R. Gambari Increase in globin mRNA content in human erythroid cells treated with angelicin analogs Int. J. Hematol. 90 2009 318 327
27. C.J. Bakkenist, and M.B. Kastan Initiating cellular stress response Cell 118 2004 9 17
28. J.N. Sarkaria, R.S. Tibbetts, E.C. Busby, A.P. Kennedy, D.E. Hill, and R. Tt Abraham Inhibition of phosphoinositide 3-kinase related kinases by the radiosensitizing agent wortmannin Cancer Res. 57 1998 4375 4382
29. J.N. Sarkaria, E.C. Busby, R.S. Tibbetts, P. Roos, Y. Taya, L.M. Karnitz, and R.T. Abraham Inhibition of ATM and ATR kinase activity by the radiosensitizing agent, caffeine Cancer Res. 59 1999 4375 4382
30. E. Brognara, I. Lampronti, G. Breveglieri, A. Accetta, R. Corradini, A. Manicardi, M. Borgatti, A. Canella, C. Multineddu, R. Marchelli, and R. Gambari C(5) modified uracil derivatives showing antiproliferative and erythroid differentiation inducing activities on human chronic myelogenous leukemia K562 cells Eur. J. Pharmacol. 672 2011 30 37
31. M. Canton, S. Caffieri, F. Dall'Acqua, and F. Di Lisa PUVA-induced apoptosis involves mitochondrial dysfunction caused by the opening of the permeability transition pore FEBS Lett. 522 2002 168 172
32. S. Aoki, D. Kong, K. Matsui, and M. Kobayashi Smenospongine, a spongean sesquiterpene aminoquinone, induces erythroid differentiation in K562 cells Anticancer Drugs 15 2004 363 369
33. S. Aoki, D. Kong, K. Matsui, and M. Kobayashi Erythroid differentiation in K562 chronic myelogenous cells induced by crambescidin 800, a pentacyclic guanidine alkaloid Anticancer Res. 24 2004 2325 2330
34. E. Rabizadeh, V. Merkin, I. Belyaeva, M. Shaklai, and Y. Zimra Pivanex, a histone deacetylase inhibitor, induces changes in BCR-ABL expression and when combined with STI571, acts synergistically in a chronic myelocytic leukemia cell line Leukemia Res. 31 2007 1115 1123
35. J. Jakubowska, M. Wasowska-Lukawska, and M. Czyz STI571 and morpholine derivative of doxorubicin collaborate in inhibition of K562 cell proliferation by inducing differentiation and mitochondrial pathway of apoptosis Eur. J. Pharmacol. 596 2008 41 49
36. A. Puissant, S. Grosso, A. Jacquel, N. Belhacene, P. Colosetti, J.P. Cassuto, and P. Auberger Imatinib mesylate-resistant human chronic myelogenous leukemia cell lines exhibit high sensitivity to the phytoalexin resveratrol FASEB J. 22 2008 1894 1904